Idiopathic rhinitis;Idiopathische rhinitis

Laryngo- Rhino- Otologie

Volumn 85, Issue 5, 2006, Pages 361-377

  Damm, Michael ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Allergy; Antihistamines; Endoscopy; Hyperreactivity; Nasal; Neurogenic inflammation; Non allergic; Nose; Outcome; Steroids; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; BIOLOGICAL MARKER; SODIUM CHLORIDE; STEROID;

IDIOPATHIC DISEASE; IMMUNE RESPONSE; INFLAMMATION; MUCOSA; NEUROLOGIC DISEASE; NOSE SECRETION; NOSE SURGERY; PERENNIAL RHINITIS; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; RHINITIS; STANDARDIZATION; TREATMENT OUTCOME; VASOMOTOR RHINITIS;

EID: 33646550523     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-921113     Document Type: Review

References (81)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-S334
2. Bachert C, Ganzer U. Die nasale Hyperreaktivität. Die allergische Rhinitis und ihre Differential-diagnosen - Konsensusbericht zur Pathophysiologie, Klassifikation, Diagnose und Therapie. Laryngorhinootologie 1997; 76: 65-76
3. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86: 494-507
4. Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003; 24: 147-154
5. Riechelmann H. Bedeutung von Umwelt und Beruf für die Nasenschleimhaut. Laryngorhinootologie 2000; 79: 653-654
6. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, Van Cauwenberge P, Hage-Hamsten M, Wuthrich B. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-824
7. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, Li JT, Bernstein IL, Berger W, Spector S, Schuller D. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998; 81: 478-518
8. Bachert C, Borchard U, Wedi B, Klimek L, Rasp G, Riechelmann H, Schultze-Werninghaus G, Wahn U, Ring J. Allergische Rhinokonjunktivitis - Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI). Allergo J 2003; 12: 182-194
9. Garay R. Mechanisms of vasomotor rhinitis. Allergy 2004; 59 (Suppl 76): 4-9
10. Widdicombe JG. Autonomic regulation. i-NANC/e-NANC. Am J Respir Crit Care Med 1998; 158: S171-S175
11. Groneberg DA, Rabe KF, Wagner U, Fischer A. Vasoaktives Intestinales Polypeptid (VIP) im Atemtrakt: Physiologie und Pathophysiologie. Pneumologie 2004; 58: 330-338
12. Knipping S, Riederer A, Berghaus A. Nervale Regulation der respiratorischen Nasenschleimhaut. HNO 2004; 52: 471-487
13. Tai CF, Baraniuk JN. Upper airway neurogenic mechanisms. Curr Opin Allergy Clin Immunol 2002; 2: 11-19
14. Carr MJ, Undem BJ. Inflammation-induced plasticity of the afferent innervation of the airways. Environ Health Perspect 2001; 109 (Suppl 4): 567-571
15. Hauser-Kronberger C, Hacker GW, Albegger K, Muss WH, Sundler F, Arimura A, Dietze O. Distribution of two VIP-related peptides, helospectin and pituitary adenylate cyclase activating peptide (PACAP), in the human upper respiratory system. Regul Pept 1996; 65: 203-209
16. Widdicombe J. Upper airway reflexes. Curr Opin Pulm Med 1998; 4: 376-382
17. Fang SY, Shen CL. Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy 1998; 28: 228-232
18. Hauser-Kronberger C, Hacker GW, Muss W, Saria A, Albegger K. Autonomic and peptidergic innervation of human nasal mucosa. Acta Otolaryngol 1993; 113: 387-393
19. Albegger K, Hauser-Kronberger CE, Saria A, Graf AH, Bernatzky G, Hacker GW. Regulatory peptides and general neuroendocrine markers in human nasal mucosa, soft palate and larynx. Acta Otolaryngol 1991; 111: 373-378
20. Groneberg DA, Heppt W, Cryer A, Wussow A, Peiser C, Zweng M, Dinh QT, Witt C, Fischer A. Toxic rhinitis-induced changes of human nasal mucosa innervation. Toxicol Pathol 2003; 31: 326-331
21. Baraniuk JN, Ali M, Yuta A, Fang SY, Naranch K. Hypertonic saline nasal provocation stimulates nociceptive nerves, substance P release, and glandular mucous exocytosis in normal humans. Am J Respir Crit Care Med 1999; 160: 655-662
22. Baraniuk JN, Ali M, Naranch K. Hypertonic saline nasal provocation and acoustic rhinometry. Clin Exp Allergy 2002; 32: 543-550
23. Fang SY, Shen CL, Ohyama M. Distribution and quantity of neuroendocrine markers in allergic rhinitis. Acta Otolaryngol 1998; 118: 398-403
24. Heppt W, Peiser C, Cryer A, Dinh QT, Zweng M, Witt C, Fischer A, Groneberg DA. Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J Occup Environ Med 2002; 44: 924-929
25. Shirasaki H, Kanaizumi E, Watanabe K, Konno N, Sato J, Asakura K, Kataura A, Himi T. Expression of neurokinin a receptor mRNA in human nasal mucosa. Acta Otolaryngol 2004; Suppl 8: 85-89
26. Hauser-Kronberger C, Hacker GW, Franz P, Albegger K, Dietze O. CCRP and substance P in intraepithelial neuronal structures of the human upper respiratory system. Regul Pept 1997; 72: 79-85
27. Riederer A, Knipping S, Fischer A, Unger J. Immunhistochemische Untersuchungen zum Vorkommen von "calcitonin gene-related peptide" (CGRP) in der Nasenschleimhaut des Menschen. HNO 1995; 43: 724-727
28. Baraniuk JN, Kaliner MA. Neuropeptides and nasal secretion. J Allergy Clin Immunol 1990; 86: 620-627
29. Lal D. Corey JP. Vasomotor rhinitis update. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 243-247
30. Knipping S, Riederer A, Agha-Mir-Salim P, Holzhausen HJ, Berghaus A. Die klassisch-vegetative, peptiderge und nitrerge Innervation der Drüsen der menschlichen Nasenschleimhaut. Laryngorhinootologie 2001; 80: 697-703
31. Gozes I, Brenneman DE. VIP: molecular biology and neurobiological function. Mol Neurobiol 1989; 3: 201-236
32. Baraniuk JN, Lundgren JD, Okayama M, Mullol J, Merida M, Sheihamer JH, Kaliner MA. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest 1990; 86: 825-831
33. Baraniuk JN, Castellino S, Lundgren JD, Goff J, Mullol J, Merida M, Shelhamer JH, Kaliner MA. Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol 1990; 3: 165-173
34. Jaradeh SS, Smith TL, Torrico L, Prieto TE, Loehrl TA, Darling RJ, Toohill RJ. Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope 2000; 110: 1828-1831
35. Loehrl TA, Smith TL, Darling RJ, Torrico L, Prieto TE, Shaker R, Toohill RJ, Jaradeh SS. Autonomic dysfunction, vasomotor rhinitis, and extraesophageal manifestations of gastroesophageal reflux. Otolaryngol Head Neck Surg 2002; 126: 382-387
36. Hess A, Bloch W, Rocker J, Peters S, Stennert E, Addicks K, Michel O. Nachweis von Stickstoffmonoxidsynthasen bei physiologischen und pathophysiologischen Prozessen in der Nasenschleimhaut. HNO 2000; 48: 489-495
37. Giannessi F, Ursino F, Fattori B, Giambelluca MA, Scavuzzo MC, Ceccarelli F, Ruffoli R. Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis. Acta Otolaryngol 2005; 125: 65-71
38. Giannessi F, Fattori B, Ursino F, Giambelluca MA, Soldani P, Scavuzzo MC, Ruffoli R. Ultrastructural and ultracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. Acta Otolaryngol 2003; 123: 943-949
39. Olthoff A, Rohrbach S, Faber M, Gotz W, Laskawi R. Neuronal nitric oxide synthase immunoreactivity in the nasal mucosa of patients with idiopathic and allergic rhinitis. ORL J Otorhinolaryngol Relat Spec 2002; 64: 180-185
40. Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS. Idiopathic and allergic rhinitis show a similar inflammatory response. Clin Otolaryngol 2000; 25: 570-576
41. Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001; 31: 864-872
42. Powe DG, Huskisson RS, Carney AS, Jenkins D, McEuen AR, Walls AF, Jones NS. Mucosal T-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells. Allergy 2004; 59: 204-212
43. Powe DG, Jagger C, Kleinjan A, Carney AS, Jenkins D, Jones NS. "Entopy": localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy 2003; 33: 1374-1379
44. Kleinjan A, Vinke JG, Severijnen LW, Fokkens WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000; 15: 491-497
45. Pozo D, Delgado M. The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide? FASEB J 2004; 18: 1325-1334
46. Vassiliou E, Jiang X, Delgado M, Ganea D. TH2 lymphocytes secrete functional VIP upon antigen stimulation. Arch Physiol Biochem 2001; 109: 365-368
47. Damm M, Jungehulsing M, Eckel HE, Schmidt M, Theissen P. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 1999; 120: 517-523
48. Fokkens WJ. Thoughts on the pathophysiology of nonallergic rhinitis. Curr Allergy Asthma Rep 2002; 2: 203-209
49. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy 1994; 49: 1-34
50. Hansen B, Mygind N. How often do normal persons sneeze and blow the nose? Rhinology 2002; 40: 10-12
51. Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998; 7: 693-702
52. Damm M, Quante G, Jungehuelsing M, Stennert E. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope 2002; 112: 310-315
53. Damm M, Eckel HE, Streppel M, Jungehulsing M, Stennert E. Abhängigkeit des uni- und bilateralen Riechvermögens von der nasalen Strömung bei Patienten mit chronischer Rhinosinusitis. HNO 2000; 48: 436-443
54. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW, Tasman AJ, Wagenmann M. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (Sektion HNO) gemeinsam mit der Arbeitsgemeinschaft Klinische Immunologie. Laryngorhinootologie 2003; 82: 183-188
55. Goldschmidt O, Mösges R, Klimek L, Hauswald B, Schapowal A. Die Reaktion der Nasenschleimhaut bei gesunden Probanden auf Histaminprovokation. Allergologie 1998; 21: 141-149
56. Litvyakova LI, Baraniuk JN. Nasal provocation testing: a review. Ann Allergy Asthma Immunol 2001; 86: 355-364
57. Van Wijk RG, Mulder PG, Dieges PH. Nasal provocation with histamine in allergic rhinitis patients: clinical significance and reproducibility. Clin Exp Allergy 1989; 19: 293-298
58. Marquez F, Sastre J, Hernandez G, Cenjor C, Sanchez-Hernandez JM, Sanchez J, Gutierrez R, Sanabria J. Nasal hyperreactivity to methacholine measured by acoustic rhinometry in asymptomatic allergic and perennial nonallergic rhinitis. Am J Rhinol 2000; 14: 251-256
59. Braat JP, Mulder PG, Fokkens WJ, van Wijk RG, Rijntjes E. Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med 1998; 157: 1748-1755
60. Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PG, Blom HM, Fokkens WJ. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy 2003; 58: 754-761
61. Heppt W. Zytologie der Nasenschleimhaut. Berlin, Heidelberg, New York: Springer, 1995
62. Kramer MF, Burow G, Pfrogner E, Rasp G. In vitro diagnosis of chronic nasal inflammation. Clin Exp Allergy 2004; 34: 1086-1092
63. Riechelmann H, Deutschte T, Friemel E, Gross HJ, Bachem M. Biological markers in nasal secretions. Eur Respir J 2003; 21: 600-605
64. Shahab R, Phillips DE, Jones AS. Prostaglandins, leukotrienes and perennial rhinitis. J Laryngol Otol 2004; 118: 500-507
65. Iguchi Y, Yao K, Okamoto M. A characteristic protein in nasal discharge differentiating non-allergic chronic rhinosinusitis from allergic rhinitis. Rhinology 2002; 40: 13-17
66. Tosun F, Sezen I, Gerek M, Ozkaptan Y, Yapar M, Caliskaner Z, Akman S. Electrophoretic evaluation of nasal discharge in patients with allergic rhinitis and vasomotor rhinitis. Am J Rhinol 2002; 16: 141-144
67. Long A, McFadden C, De Vine D, Chew P, Kupelnick B, Lau J. Management of allergic and nonallergic rhinitis. Evid Rep Technol Assess (Summ) 2002; 5: 1-6
68. Webb DR, Meltzer EO, Finn AF Jr, Rickard KA, Pepsin PJ, Westlund R, Cook CK. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia. Ann Allergy Asthma Immunol 2002; 88: 385-390
69. Banov CH, Lieberman P. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001; 86: 28-35
70. Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy 2004; 59 (Suppl 76): 16-22
71. Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth VW. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997; 27: 796-801
72. Gerth VW, Terreehorst IT, Mulder PG, Garrelds IM, Blom HM, Popering S. Intranasal capsaicin is lacking therapeutic effect in perennial allergic rhinitis to house dust mite. A placebo-controlled study. Clin Exp Allergy 2000; 30: 1792-1798
73. Wolf G, Anderhuber W, Hauser-Kronberger C, Saria A. Die Behandlung der unspezifischen hyperreflektorischen Rhinopathie (vasomotorischen Rhinitis) mit Capsaicin. Laryngorhinootologie 1995; 74: 289-293
74. Riechelmann H, Davris S, Bader D. Behandlung der perennialen nichtallergischen Rhinopathie mit Capsaicin. HNO 1993; 41: 475-479
75. Sanico AM, Philip G, Proud D, Naclerio RM, Togias A. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy 1998; 28: 92-100
76. Kim KS, Kim SS, Yoon JH, Han JW. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol 1998; 112: 248-251
77. Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik A. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Acta Otolaryngol 2003; 123: 1060-1063
78. El Guindy A. Endoscopic transseptal vidian neurectomy. Arch Otolaryngol Head Neck Surg 1994; 120: 1347-1351
79. Fernandes CM. Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. J Laryngol Otol 1994; 108: 569-573
80. Prasanna A, Murthy PS. Vasomotor rhinitis and sphenopalatine ganglion block. J Pain Symptom Manage 1997; 13: 332-338
81. 2 laser anterior turbinectomy in the treatment of non-allergic vasomotor rhinopathia. A prospective study upon 78 patients. Rhinology 1991; 29: 267-271